AnaptysBio, Inc. is a clinical-stage biotechnology company, which engages in delivering innovative immunology therapeutics for autoimmune and inflammatory diseases. The firm’s product pipeline includes Rosnilimab, ANB033, ANB101, Jemperli, and Imsidolimab. It operates through the Biopharma and Royalty Management segments. The Biopharma segment focuses on the development and potential commercialization of innovative immunology therapeutics for autoimmune and inflammatory diseases. The Royalty Management segment manages the financial collaboration for Jemperli with GSK and for imsidolimab with Vanda. The company was founded by Andrew B. Cubitt, William J. Boyle, Kevin J. Kinsella, and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
104
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. AnaptysBio Inc market cap is $1.39B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. AnaptysBio Inc 52 week high is $72.36 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. AnaptysBio Inc 52 week low is $26.01 as of November 22, 2026.
AnaptysBio Inc stock price today is $46.63.
AnaptysBio Inc stock price yesterday was $47.40.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. AnaptysBio Inc's P/E ratio is 7.73.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. AnaptysBio Inc P/B ratio is 67.0569.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. AnaptysBio Inc 50-day moving average is $48.88.